WILMINGTON, N.C., & NEWTON, Mass.--(BUSINESS WIRE)--Pharmaceutical Product Development, LLC (PPD) has signed a license agreement to use Tessella and Berry Consultants’ FACTSTM software to create a more flexible, intuitive approach for designing both adaptive and fixed trials. The software expands PPD’s adaptive design capabilities by giving biopharmaceutical companies greater ability to use extensive simulations to investigate various study design options. These simulations are particularly useful for adaptive designs, where different options are available for making adjustments to an ongoing trial based on a set of pre-specified conditions, but they also can be used with fixed designs.
